PCS-499 Uses, Dosage, Side Effects and more
PCS-499 is under investigation in clinical trial NCT01487109 (A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients).
| Trade Name | PCS-499 |
| Generic | PCS-499 |
| Type | |
| Formula | C13H20N4O3 |
| Weight | Average: 285.359 Monoisotopic: 285.18492425 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
